1. Home
  2. ZNB vs MDAI Comparison

ZNB vs MDAI Comparison

Compare ZNB & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zeta Network Group Class A Ordinary Shares

ZNB

Zeta Network Group Class A Ordinary Shares

N/A

Current Price

$0.20

Market Cap

37.4M

ML Signal

N/A

MDAI

Spectral AI Inc.

N/A

Current Price

$1.40

Market Cap

43.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZNB
MDAI
Founded
N/A
2013
Country
United States
United States
Employees
14
78
Industry
Engineering & Construction
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.4M
43.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ZNB
MDAI
Price
$0.20
$1.40
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.25
AVG Volume (30 Days)
1.8M
194.8K
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$1.04
52 Week High
$5.22
$3.21

Technical Indicators

Market Signals
Indicator
ZNB
MDAI
Relative Strength Index (RSI) 32.73 39.28
Support Level $0.19 $1.32
Resistance Level $0.30 $1.76
Average True Range (ATR) 0.03 0.07
MACD 0.01 -0.00
Stochastic Oscillator 8.79 26.67

Price Performance

Historical Comparison
ZNB
MDAI

About ZNB Zeta Network Group Class A Ordinary Shares

Zeta Network Group is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: